Arena Pharmaceuticals EPS misses by $0.17, misses on revenue

|About: Arena Pharmaceuticals, Inc. (ARNA)|By:, SA News Editor

Arena Pharmaceuticals (NASDAQ:ARNA): Q2 GAAP EPS of -$1.24 misses by $0.17.

Revenue of $1.02M (-74.4% Y/Y) misses by $1.89M.

Press Release

Subscribe for full text news in your inbox